Lv1
64 积分 2024-11-20 加入
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
5个月前
已完结
The microbiology laboratory should intensively cooperate with the clinicians to improve the diagnostic level of pulmonary infections
11个月前
已完结
Respiratory syncytial virus infection and novel interventions
11个月前
已完结
Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)
11个月前
已完结
皖公网安备34019202002308
